Exabis Library
Welcome to the e-CCO Library!
P603: INSPIRE: 6-month interim analysis from an observational post-marketing registry on the effectiveness and safety of darvadstrocel in patients with Crohn’s disease and complex perianal fistulas
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P603: Paediatric onset inflammatory bowel disease is not associated with more disability compared with adult onset disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P603: Patient characteristics and adverse effects in biologic treatment of Crohn’s Disease and Ulcerative Colitis: A nationwide Danish cohort study years 2015-2018.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P603: Real-world Scottish experience of anti-TNF therapy in paediatric Crohn's disease 2016-2020 against the ECCO-ESPGHAN recommendations
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P603: Vedolizumab trough levels at Week 6 predict endoscopic and clinical remission in inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P604 Can we reduce intravenous monoclonal antibody observation times without compromising patient safety? A single centre retrospective observational study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P604: Biologics with or without a combination with 5-ASA in ulcerative colitis: frequency of usage and effect on the course of disease in the Swiss IBD-Cohort study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P604: Evaluation of management heterogeneity and complications of Crohn’s disease in Catalonia. A population quality care study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P604: Infection Risk in Elderly Patients with Inflammatory Bowel Disease under anti-TNF, ustekinumab or vedolizumab biologic therapies: A Prospective Multicenter observational One-Year follow-up comparative study.
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P604: Interest in the addition of azathioprine (AZA) to the switch of anti-TNF in IBD patients in loss of response with undetectable anti-TNF trough levels and anti-drug antibodies: A prospective randomised trial
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P604: Usefulness of stool hemoglobin and fecal calprotectin for detecting of mild to moderate ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P605 Eight-year efficacy and safety of azathioprine treatment in the maintenance of steroid-free remission in inflammatory bowel disease patients
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P605: CRP reduction rate following initiation of anti-tumour necrosis factor-α induction therapy predicts secondary loss of response in patients with Crohn's disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P605: Development and validation of an objective disability index for Inflammatory Bowel Disease patients (ODIBD)
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P605: Immunogenicity and safety of standard and third dose SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases; a prospective cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P605: Rapid detection of anti-infliximab antibodies in inflammatory bowel disease patients treated with the reference biologic or the biosimilar CT-P13: performance comparison with ELISA
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P605: Real life efficacy of tofacitinib in different situation in ulcerative colitis: a retrospective worldwide multicentre collaborative study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P605: Transanal minimally invasive proctectomy (TaMIP) in patients with Crohn’s disease: A cohort study from the TaTME international database
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P606 Exclusive enteral nutrition with a polymeric diet is efficacious in inducing remission in adults with active Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P606: Adherence to endoscopic surveillance guidelines for advanced lesions and colorectal cancer in Inflammatory Bowel Disease in Spain: a collaborative study of AEG and GETECCU.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM